{
    "nctId": "NCT01929720",
    "briefTitle": "Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer Survivors",
    "officialTitle": "Worry, Uncertainty and Insomnia: A Cognitive-behavioral Intervention for Cancer Survivors",
    "overallStatus": "COMPLETED",
    "conditions": "Anxiety Disorder, Worry, Uncertainty, Sleep Disorders, Insomnia, Fatigue, Pain, Depression, Cognitive-behavioral Therapy, Psychological Intervention, Esophageal Cancer, Pancreatic Cancer, Leukemia, Lung Cancer, Multiple Myeloma, Ovarian Neoplasm, Stage III or IV Cervical or Uterine Cancer, Stage IIIB, IIIC, or IV Breast Cancer, Glioblastoma Multiforme, Relapsed Lymphoma, Stage III or IV Colorectal Cancer, Stage IIIC or IV Melanoma",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 33,
    "primaryOutcomeMeasure": "Changes in worry on the Penn State Worry Questionnaire",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* lung cancer\n* stage III or IV colorectal cancer\n* pancreatic cancer\n* esophageal cancer\n* multiple myeloma\n* leukemia\n* stage IIIC and IV melanoma\n* ovarian cancer\n* stage III \\& IV cervical cancer\n* stage III \\& IV uterine cancer\n* stage IIIB, IIIC, and IV breast cancer\n* glioblastoma multiforme\n* early relapse (\\< 1 year) lymphoma\n\nExclusion Criteria:\n\n* co-morbid immunologic disease (i.e. rheumatoid arthritis, systemic lupus)\n* neurologic disease (i.e. multiple sclerosis, Parkinson's, Alzheimer's) that would affect neuro-immune assessment or completion of study questionnaires\n* mania (if patient has bipolar disorder)\n* active substance abuse disorders such as alcohol dependence and cocaine abuse will also be excluded",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}